Simply in the past decade, researchers have actually understood the huge function that the microbes living inside and on us play in our health. The human microbiome, and especially the gut microbiome, has been connected to several chronic diseases, including diabetes. An out of balance microbiome structure has been found in patients with diabetes, who tend to have a less diverse gut microbiome as compared to healthy people. List.
Some companies are establishing diabetes treatments targeting the microbiome. The French Valviotis is presently performing preclinical testing of a drug targeted at increasing the microbiome variety as a treatment for type 2 diabetes. Although appealing, the microbiome field is very young and its complexity makes it hard to establish causation after finding correlation.
That world may not be so far away, as lots of companies are developing non-invasive techniques to substitute finger pricking. List. Stability Applications has actually established a gadget called GlucoTrack that can determine glucose using electromagnetic waves and is currently offered in Europe. Similar technologies are turning up, with GlucoSense in London utilizing laser light to determine sugar levels and MediWise utilizing radio waves.
The GlucoWise sensor prototypePatches are also ending up being a popular kind of determining blood sugar without needles, such as FreeStyle Libre, an inch-wide patch that can be used for approximately 2 weeks. At the University of Bath, researchers are developing a graphene spot that could supply higher precision by measuring sugar levels individually in numerous hair roots – List.
On the other hand, Senseonic and Roche are working on a device that is implanted under the skin. List. Still, non-invasive choices to measure blood sugar level typically face concerns concerning accuracy. The popular glucose-measuring contact lens that Google announced in 2014 was dismissed as “technically infeasible” and further developments will be needed to reach the degree of accuracy of finger-pricking techniques.
Scientists are currently speculating about microchips that can identify diabetes type 1 before the signs appear or nanorobots taking a trip in the blood stream while they measure glucose and provide insulin – List.”There’s little fiction left in this. I highly think that microrobotics will come and will be part of our drug shipment within the next ten years,” said Tomas Landh, Director of Technique and Innovation Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Annual MeetingWhatever the future brings, it will unquestionably make a substantial difference in the lives of millions of people worldwide.